Jody Garry, Douglas R Geraets. Show Affiliations »
Abstract
Entities: Species
Mesh： See more » Anticoagulants/administration & dosageAnticoagulants/pharmacokineticsAryl Hydrocarbon Hydroxylases/drug effectsAryl Hydrocarbon Hydroxylases/metabolismCytochrome P-450 CYP1A2/drug effectsCytochrome P-450 CYP1A2/metabolismCytochrome P-450 CYP2C9Dose-Response Relationship, DrugDrug InteractionsDrug MonitoringHumansInternational Normalized RatioPrednisone/adverse effectsSmoking CessationTobacco/adverse effectsWarfarin/administration & dosageWarfarin/pharmacokinetics
Substances： See more » AnticoagulantsWarfarinCYP2C9 protein, humanCytochrome P-450 CYP2C9Aryl Hydrocarbon HydroxylasesCytochrome P-450 CYP1A2Prednisone
Year: 2007 PMID： 17420191 DOI： 10.2146/ajhp060666
Source DB: PubMed Journal: Am J Health Syst Pharm ISSN： 1079-2082 Impact factor: 2.637